Patrick Wood
Stock Analyst at UBS
(0.53)
# 4,289
Out of 4,983 analysts
439
Total ratings
48.5%
Success rate
-3.1%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Reiterated: Buy | $22 → $25 | $21.43 | +16.66% | 2 | Sep 15, 2026 | |
| COO The Cooper Companies | Rated: Hold | $75 → $66 | $53.78 | +22.73% | 16 | Sep 10, 2026 | |
| MDT Medtronic | Rated: Buy | $100 → $110 | $92.77 | +18.57% | 17 | Sep 3, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $25 → $28 | $22.03 | +27.10% | 2 | Sep 2, 2026 | |
| SOLV Solventum | Rated: Buy | $101 | $87.53 | +15.39% | 14 | Aug 20, 2026 | |
| BDX Becton, Dickinson and Company | Rated: Buy | $190 → $205 | $181.38 | +13.02% | 17 | Aug 12, 2026 | |
| PODD Insulet | Rated: Hold | $150 | $141.55 | +5.97% | 17 | Aug 12, 2026 | |
| TFX Teleflex | Reiterated: Hold | $145 → $158 | $125.59 | +25.81% | 16 | Aug 11, 2026 | |
| SI Shoulder Innovations | Rated: Buy | $27 → $28 | $17.80 | +57.30% | 8 | Aug 10, 2026 | |
| STE STERIS | Rated: Buy | $275 → $270 | $208.04 | +29.78% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 | $17.23 | +4.47% | 15 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5.5 → $6.3 | $5.32 | +18.42% | 18 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $8 | $8.08 | -0.99% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $120 | $94.25 | +27.32% | 11 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $16 | $10.28 | +55.64% | 7 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $19.47 | +2.72% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $80 → $77 | $86.66 | -11.15% | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $25 | $18.04 | +38.58% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 → $23 | $16.77 | +37.15% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $118 → $67 | $43.55 | +53.85% | 21 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $72 → $172 | $161.42 | +6.55% | 10 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $137 → $125 | $102.23 | +22.27% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $15 → $25 | $23.02 | +8.60% | 15 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $96 | $87.93 | +9.18% | 16 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $17.80 | +186.52% | 1 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $86 → $110 | $88.25 | +24.65% | 17 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $100 → $82 | $74.16 | +10.57% | 5 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $10 → $19 | $15.10 | +25.83% | 4 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $39 | $72.74 | -46.38% | 6 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $650 → $500 | $383.54 | +30.36% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $13 → $20 | $21.24 | -5.84% | 11 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $445 → $400 | $280.13 | +42.79% | 7 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 65.31 | CHF 53.70 | +21.61% | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $32.12 | +49.44% | 2 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $35 | $49.57 | -29.39% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $85 | $64.45 | +31.90% | 15 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $205 | $111.61 | +83.68% | 5 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $185 | $281.67 | -34.32% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $195 → $220 | $366.31 | -39.94% | 2 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $266 | $318.87 | -16.58% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $560 → $656 | $658.32 | -0.35% | 2 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $68 | $80.36 | n/a | 1 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 | $15.86 | n/a | 1 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $220 | $269.44 | n/a | 1 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $1.36 | n/a | 3 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18 | $0.03 | n/a | 2 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 | $22.67 | n/a | 1 | Aug 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $16 | $24.68 | n/a | 2 | Oct 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 1,473p | 1,036p | n/a | 1 | Feb 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €35.31 → €45.00 | €21.63 | n/a | 2 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €64.58 → €42.00 | €45.82 | n/a | 2 | Dec 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 267.00 | CHF 547.00 | n/a | 1 | Jan 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $22.07 | n/a | 1 | Jul 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $183.09 | n/a | 2 | Dec 11, 2017 |
Beta Bionics
Sep 15, 2026
Reiterated: Buy
Price Target: $22 → $25
Current: $21.43
Upside: +16.66%
The Cooper Companies
Sep 10, 2026
Rated: Hold
Price Target: $75 → $66
Current: $53.78
Upside: +22.73%
Medtronic
Sep 3, 2026
Rated: Buy
Price Target: $100 → $110
Current: $92.77
Upside: +18.57%
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $22.03
Upside: +27.10%
Solventum
Aug 20, 2026
Rated: Buy
Price Target: $101
Current: $87.53
Upside: +15.39%
Becton, Dickinson and Company
Aug 12, 2026
Rated: Buy
Price Target: $190 → $205
Current: $181.38
Upside: +13.02%
Insulet
Aug 12, 2026
Rated: Hold
Price Target: $150
Current: $141.55
Upside: +5.97%
Teleflex
Aug 11, 2026
Reiterated: Hold
Price Target: $145 → $158
Current: $125.59
Upside: +25.81%
Shoulder Innovations
Aug 10, 2026
Rated: Buy
Price Target: $27 → $28
Current: $17.80
Upside: +57.30%
STERIS
Aug 7, 2026
Rated: Buy
Price Target: $275 → $270
Current: $208.04
Upside: +29.78%
Aug 7, 2026
Reiterated: Hold
Price Target: $18
Current: $17.23
Upside: +4.47%
Aug 6, 2026
Reiterated: Hold
Price Target: $5.5 → $6.3
Current: $5.32
Upside: +18.42%
Aug 6, 2026
Reiterated: Buy
Price Target: $7 → $8
Current: $8.08
Upside: -0.99%
Aug 6, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $94.25
Upside: +27.32%
Aug 5, 2026
Rated: Buy
Price Target: $15 → $16
Current: $10.28
Upside: +55.64%
Aug 5, 2026
Reiterated: Hold
Price Target: $20
Current: $19.47
Upside: +2.72%
Aug 5, 2026
Rated: Hold
Price Target: $80 → $77
Current: $86.66
Upside: -11.15%
Aug 4, 2026
Reiterated: Buy
Price Target: $24 → $25
Current: $18.04
Upside: +38.58%
Jul 30, 2026
Initiated Coverage: Buy
Price Target: $21 → $23
Current: $16.77
Upside: +37.15%
Jul 30, 2026
Reiterated: Buy
Price Target: $118 → $67
Current: $43.55
Upside: +53.85%
Jul 30, 2026
Reiterated: Hold
Price Target: $72 → $172
Current: $161.42
Upside: +6.55%
Jul 28, 2026
Rated: Buy
Price Target: $137 → $125
Current: $102.23
Upside: +22.27%
Jul 28, 2026
Rated: Hold
Price Target: $15 → $25
Current: $23.02
Upside: +8.60%
Jul 28, 2026
Reiterated: Buy
Price Target: $75 → $96
Current: $87.93
Upside: +9.18%
Jul 28, 2026
Initiated Coverage: Buy
Price Target: $51
Current: $17.80
Upside: +186.52%
Jul 28, 2026
Upgraded: Buy
Price Target: $86 → $110
Current: $88.25
Upside: +24.65%
Jul 28, 2026
Initiated Coverage: Hold
Price Target: $100 → $82
Current: $74.16
Upside: +10.57%
Jul 28, 2026
Initiated Coverage: Hold
Price Target: $10 → $19
Current: $15.10
Upside: +25.83%
Jul 28, 2026
Downgraded: Sell
Price Target: $39
Current: $72.74
Upside: -46.38%
Jul 28, 2026
Upgraded: Buy
Price Target: $650 → $500
Current: $383.54
Upside: +30.36%
Jul 28, 2026
Initiated Coverage: Sell
Price Target: $13 → $20
Current: $21.24
Upside: -5.84%
Jul 28, 2026
Upgraded: Buy
Price Target: $445 → $400
Current: $280.13
Upside: +42.79%
Mar 11, 2026
Reiterated: Hold
Price Target: CHF 65.31
Current: CHF 53.70
Upside: +21.61%
Feb 25, 2026
Reiterated: Buy
Price Target: $48
Current: $32.12
Upside: +49.44%
Feb 17, 2026
Reiterated: Hold
Price Target: $35
Current: $49.57
Upside: -29.39%
Feb 5, 2026
Reiterated: Hold
Price Target: $80 → $85
Current: $64.45
Upside: +31.90%
Dec 2, 2025
Reiterated: Buy
Price Target: $195 → $205
Current: $111.61
Upside: +83.68%
Nov 11, 2025
Reiterated: Hold
Price Target: $185
Current: $281.67
Upside: -34.32%
Nov 11, 2025
Reiterated: Buy
Price Target: $195 → $220
Current: $366.31
Upside: -39.94%
Nov 6, 2025
Reiterated: Hold
Price Target: $266
Current: $318.87
Upside: -16.58%
Oct 28, 2025
Reiterated: Buy
Price Target: $560 → $656
Current: $658.32
Upside: -0.35%
Aug 12, 2025
Reiterated: Buy
Price Target: $68
Current: $80.36
Upside: n/a
Aug 4, 2025
Reiterated: Hold
Price Target: $12
Current: $15.86
Upside: n/a
Jul 23, 2025
Reiterated: Buy
Price Target: $220
Current: $269.44
Upside: n/a
May 27, 2025
Reiterated: Hold
Price Target: $6
Current: $1.36
Upside: n/a
Jun 13, 2024
Reiterated: Hold
Price Target: $18
Current: $0.03
Upside: n/a
Aug 24, 2023
Downgraded: Hold
Price Target: $34
Current: $22.67
Upside: n/a
Oct 4, 2022
Reiterated: Hold
Price Target: $30 → $16
Current: $24.68
Upside: n/a
Feb 22, 2022
Reiterated: Buy
Price Target: 1,473p
Current: 1,036p
Upside: n/a
Jul 28, 2021
Downgraded: Hold
Price Target: €35.31 → €45.00
Current: €21.63
Upside: n/a
Dec 3, 2020
Downgraded: Hold
Price Target: €64.58 → €42.00
Current: €45.82
Upside: n/a
Jan 31, 2019
Downgraded: Hold
Price Target: CHF 267.00
Current: CHF 547.00
Upside: n/a
Jul 9, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $22.07
Upside: n/a
Dec 11, 2017
Upgraded: Buy
Price Target: n/a
Current: $183.09
Upside: n/a